Literature DB >> 17213683

Expression of cancer cachexia-related factors in human cancer xenografts: an immunohistochemical analysis.

Shingo Kamoshida1, Kana Watanabe, Mai Suzuki, Yasuyoshi Mizutani, Kazuki Sakamoto, Yoshikazu Sugimoto, Toshinori Oka, Masakazu Fukushima, Yutaka Tsutsumi.   

Abstract

We immunohistochemically evaluated the involvement of five cancer cachexia-related factors, including leukemia-inhibitory factor (LIF), zinc-alpha2-glycoprotein (ZAG), interleukin 6 (IL-6), proteolysis-inducing factor (PIF) and tumor necrosis factor alpha (TNF alpha) in causing cancer cachexia. Twenty-six xenografts implanted into mice were examined for the expression of the cancer cachexia-related factors, in relation to the body weight loss of the hosts. Five xenografts were categorized in the cachectic group, and the remaining 21 xenografts belonged to the non-cachectic group. LIF was extensively expressed in both the cachectic and non-cachectic groups. ZAG and IL-6 were expressed in one of the cachectic and some non-cachectic xenografts. PIF and TNF alpha were detected in one and two non-cachectic xenografts, respectively, but in none of the cachectic ones. Any of five factors examined were not conclusive for causing cancer cachexia in the murine xenograft model. Further analysis is needed in order to elucidate the mechanisms responsible for cancer cachexia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17213683     DOI: 10.2220/biomedres.27.275

Source DB:  PubMed          Journal:  Biomed Res        ISSN: 0388-6107            Impact factor:   1.203


  2 in total

1.  Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.

Authors:  Melissa J Puppa; Song Gao; Aditi A Narsale; James A Carson
Journal:  FASEB J       Date:  2013-10-21       Impact factor: 5.191

2.  The Warburg effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells.

Authors:  Feng Wang; Hongyi Liu; Lijuan Hu; Yunfei Liu; Yijie Duan; Rui Cui; Wencong Tian
Journal:  BMC Cancer       Date:  2018-04-02       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.